Management of SAS and cardiovascular disease risk should be closely linked. It is important to screen for cardiovascular disease risk in patients with SAS and vice versa. CSA/CSR may be improved by ventilation strategies in heart failure, but benefit remains to be proven. For OSA, although CPAP may reduce cardiovascular disease risk, its main benefit is symptom control. In the longer term, CPAP should be used alongside standard cardiovascular risk reduction strategies including robust weight management programmes, with referral for bariatric surgery in appropriate cases. CPAP and NIV should be considered for acute admissions with decompensated cardiac failure. © Royal College of Physicians, 2011. All rights reserved.
CITATION STYLE
Pepperell, J. C. (2011). Sleep apnoea syndromes and the cardiovascular system. Clinical Medicine, Journal of the Royal College of Physicians of London. Royal College of Physicians. https://doi.org/10.7861/clinmedicine.11-3-275
Mendeley helps you to discover research relevant for your work.